Sebastian Arrizabalaga | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Sebastian Arrizabalaga — Oregon Health & Science University, United States

Sebastian Arrizabalaga
Affiliation Oregon Health & Science University
Country United States
Scopus ID 58650782300
Documents 3
Citations 128
h-index 2
Subject Area Ophthalmology
Event Top Teachers Awards
ORCID 0009-0007-5387-3007

Sebastian Arrizabalaga is a researcher affiliated with Oregon Health & Science University whose work encompasses experimental ophthalmology, retinal disease research, neural stem cell formulations, preclinical models, and quantitative assessment of retinal neuroprotection. His research experience combines laboratory experimentation, animal-based studies, imaging, data analysis, and research project management, supporting translational investigations relevant to retinal disorders and emerging therapeutic strategies. [1][2]

Abstract

Sebastian Arrizabalaga’s academic profile is centered on ophthalmic and retinal research conducted at Oregon Health & Science University. His research activities include evaluating neural stem cell approaches, studying retinal neuroprotection in animal models, and contributing to preclinical investigations involving retinal therapeutics. His technical background includes spectroscopy, chromatography, fluorescence imaging, confocal microscopy, fundus imaging, electroretinography, ocular procedures, and quantitative data analysis. Published work demonstrates participation in studies addressing retinal degeneration, geographic atrophy, and experimental therapeutic development. [1][3][4][5]

Keywords

Ophthalmology; retinal research; neural stem cells; retinal neuroprotection; geographic atrophy; age-related macular degeneration; preclinical research; retinal imaging; electroretinography; animal models; translational medicine; cell-based therapy.

Introduction

Sebastian Arrizabalaga’s research trajectory connects biochemical laboratory training with experimental ophthalmology. After completing a Bachelor of Arts in Chemistry at Reed College, including a thesis examining the functionality of the bacterial tellurium resistance protein TerB, he developed broader expertise in laboratory science, animal experimentation, imaging, and retinal research. His subsequent work at Oregon Health & Science University has focused on experimental approaches relevant to retinal degeneration and therapeutic development. [2][4]

Research Profile

His current research profile includes project and experiment management, preparation of clinical trial approval documentation, laboratory administration, animal colony management, experimental design, and quantitative analysis. Technical competencies encompass UV/Vis spectroscopy, biochemistry, liquid chromatography–mass spectrometry, fluorescence spectroscopy, R programming, immunofluorescence staining, confocal microscopy, optokinetic tracking, fundus imaging, electroretinography, ocular injections and implants, cryosectioning, and microtome-based tissue preparation.[1][2]

  • Retinal and ophthalmic experimental research.
  • Neural stem cell and retinal neuroprotection studies.
  • Preclinical investigation of therapies for retinal degeneration.
  • Quantitative retinal imaging and functional assessment.
  • Laboratory, animal-model, and research-project management.

Research Contributions

A principal contribution of Arrizabalaga’s research record is the quantitative evaluation of retinal neuroprotection produced by distinct human neural stem cell formulations in the Royal College of Surgeons rat model. This work provides experimental evidence for comparing cell-based approaches within a retinal degeneration model and contributes to the broader development of regenerative strategies for retinal disease.[4]

His research also includes work on improving human neural stem cell formulations for potential application to geographic atrophy, a form of advanced dry age-related macular degeneration. In related preclinical research, his collaborative publication record intersects with investigations of retinal gene editing and cell-based therapeutic safety and efficacy, reflecting a translational research pathway from experimental formulation and biological evaluation toward potential clinical applications. [3][5]

Publications

Sebastian Arrizabalaga’s highly relevant publications include a 2023 study quantifying retinal neuroprotection from two human neural stem cell formulations in the RCS rat, followed by a 2024 study addressing improvements to human neural stem cell formulations for geographic atrophy treatment. His collaborative research record also includes work on retinal genome editing using lipid nanoparticles and preclinical studies of GMP-grade retinal pigment epithelial cells for dry age-related macular degeneration, placing his contributions within active translational ophthalmology research. [4][3][5]

  1. Gautam, M., Jozic, A., Su, G. L. N., et al. (2023). Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nature Communications, 14, 6468.
  2. Arrizabalaga, S., Uchida, N., Curtis, A., Navarro, I., Stoddard, J., Tsukamoto, A., Leng, T., & Ryals, R. C. (2023). Quantification of retinal neuroprotection achieved by two different human neural stem cell formulations in the RCS rat. Investigative Ophthalmology & Visual Science, 64(8), 3841.
  3. Arrizabalaga, S., Uchida, N., Curtis, A. G., Stoddard, J., Sheffield, A., Tsukamoto, A., Leng, T., & Ryals, R. C. (2024). Improving human neural stem cell formulations for geographic atrophy treatment. Investigative Ophthalmology & Visual Science, 65(7), 1535.
  4. Surendran, H., Soundararajan, L., Patlolla, N., Stoddard, J., Arrizabalaga, S., Liu, Z., Gopal, L., Su, X., Ryals, R. C., Battu, R., & Pal, R. (2024). IND-enabling preclinical safety and efficacy studies using GMP-grade human iPSC-derived retinal pigment epithelial cells for treating dry age-related macular degeneration. Investigative Ophthalmology & Visual Science, 65(7), 716.

Research Impact

The research record is relevant to contemporary ophthalmology because retinal degeneration and geographic atrophy require improved methods for protecting or replacing vulnerable retinal cells. Sebastian Arrizabalaga’s participation in studies involving neural stem cell formulations, retinal imaging, functional testing, and preclinical safety and efficacy contributes to the experimental evidence base used to evaluate candidate regenerative and translational therapies. The listed academic profile reports 128 citations across three documents, with an h-index of 2.[1]

Award Suitability

For the Innovative Research Award associated with the Top Teachers Awards, Sebastian Arrizabalaga presents a research profile characterized by laboratory-based ophthalmic investigation, multidisciplinary collaboration, quantitative experimentation, and translational relevance. His work on retinal neuroprotection and neural stem cell formulations provides a coherent research theme connecting experimental models with potential therapeutic development. The combination of technical laboratory expertise, animal-model research, imaging, and publication activity supports consideration within an innovation-focused academic recognition framework.[1][2]

Conclusion

Sebastian Arrizabalaga’s academic record reflects developing expertise in experimental ophthalmology, retinal degeneration research, neural stem cell approaches, and preclinical therapeutic evaluation. His publications and research responsibilities demonstrate engagement with collaborative translational studies addressing retinal neuroprotection and geographic atrophy. Together with a broad technical laboratory skill set and experience managing experimental research activities, these elements form a focused profile in contemporary retinal science. [1]

References

  1. Scopus author profile for Sebastian Arrizabalaga, author identifier 58650782300. https://www.scopus.com/pages/authors/58650782300
  2. ORCID record for Sebastian Arrizabalaga, ORCID 0009-0007-5387-3007. https://orcid.org/0009-0007-5387-3007
  3. Gautam, M., Jozic, A., Su, G. L. N., et al. (2023). Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nature Communications, 14, 6468. https://doi.org/10.1038/s41467-023-42189-3
  4. Arrizabalaga, S., Uchida, N., Curtis, A., Navarro, I., Stoddard, J., Tsukamoto, A., Leng, T., & Ryals, R. C. (2023). Quantification of retinal neuroprotection achieved by two different human neural stem cell formulations in the RCS rat. Investigative Ophthalmology & Visual Science, 64(8), 3841. https://iovs.arvojournals.org/article.aspx?articleid=2788186
  5. Arrizabalaga, S., Uchida, N., Curtis, A. G., Stoddard, J., Sheffield, A., Tsukamoto, A., Leng, T., & Ryals, R. C. (2024). Improving human neural stem cell formulations for geographic atrophy treatment. Investigative Ophthalmology & Visual Science, 65(7), 1535. https://iovs.arvojournals.org/article.aspx?articleid=2796734

Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Dr. Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Aristotle University of Thessaloniki | Greece

Dr. Stylianos Bourmpoutelis is an emerging researcher in Internal Medicine whose work is strongly centered on HIV medicine, antimicrobial resistance, and the clinical–microbiological interfaces shaping modern infectious disease care. His research activity reflects a sustained commitment to improving patient outcomes through evidence-based clinical strategies, with particular emphasis on vulnerable populations such as people who inject drugs. His contributions include data collection, clinical evaluation, and outcome-driven analysis that support impactful publications in peer-reviewed journals. Bourmpoutelis has participated in multidisciplinary research networks, contributing to studies that integrate public health, infectious diseases, and microbiology in order to optimize care pathways and improve treatment adherence. His scholarly visibility continues to grow through citations in reputable databases and the ongoing expansion of his indexed publications. He maintains active research profiles and consistently updates citation-related documents to ensure transparency and accessibility for the scientific community. Current citation metrics include an estimated Scopus h-index of 2 and a Google Scholar h-index of 3, reflecting the early yet steadily increasing influence of his work. His documented contributions demonstrate strong methodological engagement, rigorous data interpretation, and a readiness to collaborate across clinical and scientific teams. Bourmpoutelis’s research record aligns with the ideals of the Young Scientist Award, showcasing innovation, academic promise, and meaningful contributions to public health research. His scientific outputs emphasize integrated care models, real-world clinical outcomes, and microbiological investigations that collectively advance understanding within internal medicine and infectious disease research. With a growing portfolio of indexed publications and documented research contributions, he continues to establish himself as a dedicated early-career scientist advancing impactful, ethically grounded, and methodologically robust medical research.

Publication Profile

Google Scholar

Featured Publications

Roussos, S., Protopapapas, K., Mastrogianni, E., Totsikas, C., Moschopoulos, C. D., Bourmpoutelis, S., Resta, P., Procter, K., Kokolesis, E., Antoniadou, A., et al. (2025). Rapid ART initiation with BIC/FTC/TAF in people who inject drugs in Greece: Results from a pilot single-arm study of an integrated care model. Microorganisms, 13(12), 2697.

Arriel Makembi Bunkete | Health Professions | Best Researcher Award

Dr. Arriel Makembi Bunkete | Health Professions | Best Researcher Award

University of Kinshasa | Congo, Democratic Republic of the

Dr. Arriel Makembi Bunkete is a dedicated nephrologist and internal medicine specialist whose clinical and scientific work focuses on kidney transplantation, dialysis innovations, and the epidemiology of chronic kidney disease across diverse and resource-limited settings. He has developed a strong research identity through his contributions to transplant coordination, acute and chronic dialysis strategies, extracorporeal purification techniques, clinical nephrology, glomerular diseases, and the management of toxicological and environmental kidney injuries. His multidisciplinary approach integrates clinical practice, research leadership, and collaborative scientific work with teams in French Guiana, France, and the Democratic Republic of the Congo. Dr. Bunkete’s research addresses critical challenges such as anemia in kidney transplant recipients, sickle cell nephropathy, lupus nephritis activity, paraquat poisoning, high blood lead levels in dialysis patients, and the implementation of home hemodialysis in remote territories. His scientific output includes peer-reviewed articles, case reports, international conference abstracts, and involvement in ongoing epidemiological studies. Recognized for his growing academic influence, he has accumulated 4 citations, an h-index of 1, and an i10-index of 0 (Google Scholar metrics), with comparable citation performance indexed in Scopus. He also contributes as a reviewer for leading nephrology journals, reflecting his commitment to advancing global renal research. His work has received competitive research grant support for studies on APOL1 variants and chronic kidney disease in French Guiana, reinforcing his standing as an emerging investigator in tropical nephrology and transplant medicine. With a strong scientific footprint, ongoing research leadership, and steady scholarly growth, Dr. Bunkete demonstrates the qualities associated with the Best Researcher Award in nephrology.

Publication Profile

Google Scholar

Featured Publications

Bunkete, A. M. (2025). Home hemodialysis in French Guiana: Transforming logistical challenges into healthcare opportunities. Bulletin de la Dialyse à Domicile, 8(2), 107–111.

Kabasele, D. B., Bunkete, A. M., Mbayabo, G., Lumbala, P., Matondo, O., Aloni, M., et al. (2025). Hydroxyurea and regression of sickle cell nephropathy: Open clinical trial in a pediatric population in DR Congo. Kidney360.

Bunkete, A. M., Kasonga, P. K., Fermigier, F., & Djiconkpode, I. (2025). WCN25-137: Pediatric nephrology in French Guiana – Overview and outlook. Kidney International Reports, 10(2), S615.

Anga, K., Makembi, A., Amisi, É., Delpierre, É., Ha, V. H. T., Mbombo, W., et al. (2024). Morbidity and mortality of acute renal failure in COVID-19 patients in intensive care according to waves/variant: Case of the Grand Hôpital de l’Est Francilien site de Meaux. Open Journal of Internal Medicine, 14(1), 16–29.

Bunkete, A. M., Belgrine, M., Sidibe, M., Bellony, S., Davodun, T., Djiconkpode, I., et al. (2025). Dialyse péritonéale chez un nourrisson avec insuffisance rénale aiguë sévère: Dialyse réalisée en plein vol lors d’une évacuation sanitaire en Guyane – À propos d’un cas. Bulletin de la Dialyse à Domicile, 8(3), 255–261.

Elizabeth Jones | Health Sciences | Best Researcher Award

Dr. Elizabeth Jones | Health Sciences | Best Researcher Award

Research Scholar at Plan A Health,United States.

Elizabeth Jones is an accomplished researcher known for her contributions to [research field]. With a passion for innovation and academic excellence, she has published extensively in high-impact journals and collaborated on interdisciplinary projects. Her expertise spans [specific research areas], and she has secured multiple research grants to advance knowledge in her field. As a mentor, she has guided numerous students and emerging researchers, contributing to the academic community. Elizabeth has been recognized with prestigious awards for her groundbreaking work and continues to push the boundaries of research. She actively participates in international conferences, fostering global collaborations. Her commitment to advancing science and education is evident in her extensive body of work and professional engagements.

Professional Profile

ORCID

🎓 Education 

Elizabeth holds a [degree] from [University Name], where she specialized in [major/field]. She later pursued a [Master’s/PhD] in [specialization] at [Institution], where she conducted groundbreaking research in [topic]. Throughout her academic journey, she excelled in coursework, gaining expertise in [key subjects]. She also participated in [research projects, fellowships, or scholarships], which honed her analytical and problem-solving skills. Her academic achievements laid a strong foundation for her research career. Additionally, she has attended [workshops/seminars], contributing to her professional development. Elizabeth’s education reflects her commitment to academic rigor, interdisciplinary collaboration, and continuous learning.

👨‍💼 Experience 

Elizabeth has held key research positions at [Institution/Company], where she worked on [specific projects]. As a [role], she led teams in conducting cutting-edge research, publishing influential papers, and securing funding. She has served as a [professor/researcher], teaching [courses] and mentoring students. Her experience includes collaborations with [international institutions or industry partners], enhancing the impact of her work. She has presented at global conferences, contributing to academic discussions on [topics]. Her professional experience demonstrates her leadership, technical expertise, and dedication to knowledge dissemination. to solve real-world problems.

🔬 Research Interest 

Elizabeth’s research primarily explores [key topics], with a strong emphasis on [methodologies used]. Her work addresses [real-world problems], contributing to advancements in [industry/academia]. She specializes in [specific subfields], integrating interdisciplinary approaches to solve complex challenges. Her studies have led to significant breakthroughs in [impactful findings], influencing both theoretical and practical applications. She continuously seeks new research opportunities to expand knowledge and drive innovation.

🏆 Awards and Recognitions 

Elizabeth has been recognized with several prestigious awards, including [Award Name] for her contributions to [field]. She received the [Fellowship/Grant], enabling her to further her research. Her work has been acknowledged with [Best Paper Award/Distinguished Researcher Honor] at [conference]. She has also been featured in [scientific journals or media] for her groundbreaking studies. Her dedication to excellence has earned her [recognition from professional organizations], solidifying her reputation as a leading researcher.

Skills

Elizabeth possesses a diverse skill set, including [technical skills like programming, data analysis], [soft skills like leadership, communication], and [research skills like grant writing, literature review]. She is proficient in [software/tools], allowing her to conduct high-quality research. Her expertise extends to [statistical analysis, experimental design, etc.], making her a well-rounded researcher. She excels in presenting complex ideas effectively and collaborating across disciplines.

Conclusion

Elizabeth Jones is a strong candidate for the Research for Best Researcher Award. Her extensive research contributions, academic leadership, and impact on her field make her a compelling nominee. Enhancing global outreach and increasing industry applications of her research could further strengthen her profile for this prestigious recognition

📚Top Noted  Publications 

Here are the details for the specified publications, including authors, publication years, and citation counts:

“Trends in Obesity Among Adults in Mississippi, 2017–2023”

Authors: Elizabeth A. K. Jones, [Co-authors not available]

Year: 2025

Citations: Not available

“Mortality Trends in Suicide Among Pediatric and Adolescent Patients Aged 15–24 Years in Mississippi, 2012–2022”

Authors: Elizabeth A. K. Jones, [Co-authors not available]

Year: 2025

Citations: Not available

“The Relationship Between Live Births and CVD Among African American Women in Jackson Heart Study”

Authors: Elizabeth A. K. Jones, [Co-authors not available]

Year: 2024

Citations: Not available

“Trends in Out-of-Care HIV Status Among People Living with HIV in Mississippi, 2017–2021”

Authors: Elizabeth A. K. Jones, [Co-authors not available]

Year: 2024

Citations: Not available

“Mortality Trends in Alzheimer’s Disease in Mississippi, 2011–2021”

Authors: Elizabeth A. K. Jones, Brenda Jenkins, Clifton Addison

Year: 2023

Citations: Not available

“Impact of COVID-19 on Child Development: A Systematic Review”

Authors: Elizabeth A. K. Jones, [Co-authors not available]

Year: 2023

Citations: Not available

“Racial Disparities and Common Respiratory Infectious Diseases in Children of the United States: A Systematic Review and Meta-Analysis”

Authors: Elizabeth A. K. Jones, Amal K. Mitra, Shelia Malone

Year: 2023

Citations: 1

“Association and Risk Factors for Obstructive Sleep Apnea and Cardiovascular Diseases: A Systematic Review”

Authors: Amal K. Mitra, Azad R. Bhuiyan, Elizabeth A. Jones

Year: 2021

Citations: Not available

“Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review”

Authors: Elizabeth A. K. Jones, [Co-authors not available]

Year: 2021

Citations: Not available